1. Home
  2. PANL vs ALLO Comparison

PANL vs ALLO Comparison

Compare PANL & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PANL
  • ALLO
  • Stock Information
  • Founded
  • PANL 1996
  • ALLO 2017
  • Country
  • PANL United States
  • ALLO United States
  • Employees
  • PANL N/A
  • ALLO N/A
  • Industry
  • PANL Marine Transportation
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PANL Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • PANL Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • PANL 357.3M
  • ALLO 338.9M
  • IPO Year
  • PANL N/A
  • ALLO 2018
  • Fundamental
  • Price
  • PANL $4.36
  • ALLO $1.38
  • Analyst Decision
  • PANL Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • PANL 1
  • ALLO 10
  • Target Price
  • PANL N/A
  • ALLO $9.66
  • AVG Volume (30 Days)
  • PANL 274.6K
  • ALLO 3.4M
  • Earning Date
  • PANL 03-13-2025
  • ALLO 05-12-2025
  • Dividend Yield
  • PANL 9.15%
  • ALLO N/A
  • EPS Growth
  • PANL 8.62
  • ALLO N/A
  • EPS
  • PANL 0.63
  • ALLO N/A
  • Revenue
  • PANL $536,536,246.00
  • ALLO $22,000.00
  • Revenue This Year
  • PANL $13.67
  • ALLO N/A
  • Revenue Next Year
  • PANL $6.04
  • ALLO $8.30
  • P/E Ratio
  • PANL $6.94
  • ALLO N/A
  • Revenue Growth
  • PANL 7.46
  • ALLO N/A
  • 52 Week Low
  • PANL $4.35
  • ALLO $1.30
  • 52 Week High
  • PANL $8.32
  • ALLO $4.30
  • Technical
  • Relative Strength Index (RSI)
  • PANL 29.78
  • ALLO 34.13
  • Support Level
  • PANL $4.67
  • ALLO $1.49
  • Resistance Level
  • PANL $4.89
  • ALLO $1.47
  • Average True Range (ATR)
  • PANL 0.18
  • ALLO 0.13
  • MACD
  • PANL -0.07
  • ALLO -0.03
  • Stochastic Oscillator
  • PANL 0.74
  • ALLO 12.31

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: